NewslettersCancer Stem Cell NewsAPE1 shRNA-Loaded Cancer Stem Cell-Derived Extracellular Vesicles Reverse Erlotinib Resistance in Non-Small Cell Lung Cancer via the IL-6/STAT3 SignallingBy Britya Ghosh - May 25, 20220308The authors delineated the mechanistic actions of APE1/IL-6 signalling in Erlotinib resistance of non-small cell lung cancer.[Clinical and Translational Medicine]Full Article